Tomasini, Richard, 1977-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Richard Tomasini researcher
VIAF ID: 217209711 (Personal)
Permalink: http://viaf.org/viaf/217209711
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| Assignment of tumor protein p53 induced nuclear protein 1 (TP53INP1) gene to human chromosome band 8q22 by in situ hybridization. |
|
| Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition |
|
| Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness |
|
| Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma |
|
| Cloning and expression of the rat vacuole membrane protein 1 (VMP1), a new gene activated in pancreas with acute pancreatitis, which promotes vacuole formation |
|
| Cloning of IP15, a pancreatitis-induced gene whose expression inhibits cell growth |
|
| Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. |
|
| The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions. |
|
| Conséquences d'un ciblage pharmacologique de MCL-1 sur le phénotype myo-fibroblastique des fibroblastes associés au cancer du sein |
|
| Consequences of DJ-1 upregulation following p53 loss and cell transformation. |
|
| Crosstalk between TAp73 and TGF-β in fibroblast regulates iNOS expression and Nrf2-dependent gene transcription |
|
| Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma |
|
| Développement d'une matrice extracellulaire humaine pour la génération de modèles pancréatiques en 3D |
|
| Diagnostic interest of liquid biopsy in the management of early stage pancreatic ductal adenocarcinoma. |
|
| Elucidation of Tenascin-X involvement during tumor progression : focus on pancreatic carcinogenesis. |
|
| Expression Profiling in Pancreas during the Acute Phase of Pancreatitis Using cDNA Microarrays |
|
| Génomique fonctionnelle appliquée aux métastases hépatiques du cancer colorectal et aux leucémies à blastes dérivés de cellules dendritiques plasmacytoïdes |
|
| How are pancreatic tumors innervated? |
|
| Hypoxia induced tumor metabolic switch contributes to pancreatic cancer aggressiveness. |
|
| Identification of ActivinB as a novel actor in endocrine β cell plasticity during tumorigenesis of Pancreatic Neuroendocrine Tumors. |
|
| IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation |
|
| The immunosuppressive and tumorigenic potential of intercellular communication in pancreatic ductal adenocarcinoma. |
|
| Impact du dialogue entre microenvironnement et cellules cancéreuses dans l'adénocarcinome canalaire pancréatique |
|
| Impact of intra-tumoral microenvironment and epithelial cells crosstalk in pancreatic adenocarcinoma. |
|
| Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway |
|
| LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma |
|
| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines |
|
| Nouvelle perspective thérapeutique pour le cancer du pancréas : ciblage des ligands des récepteurs de la famille HER exprimés par la tumeur et son microenvironnement |
|
| P53-dependent expression of the stress-induced protein (SIP). |
|
| p73: a multifunctional protein in neurobiology |
|
| p73 in Cancer. |
|
| Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models |
|
| PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. |
|
| Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance |
|
| Rôle de la cytokine Leukemia Inhibitory Factor (LIF) dans l'activation et le maintien des fibroblastes pro-invasifs lors de la carcinogénèse |
|
| Rôle des vésicules extracellulaires dans le diabète de type 1. |
|
| Rôle du stroma dans la progression de l'adénocarcinome pancréatique |
|
| Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling |
|
| SIP/TP53INP1, a new stress gene that induces p53 expression to promote cell cycle arrest and apoptosis. |
|
| SIP/TP53INP1, un nouveau gène de stress, régule positivement p53 pour induire l'arrêt du cycle cellulaire et l'apoptose |
|
| Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. |
|
| Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer |
|
| Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling |
|
| TAp73 depletion accelerates aging through metabolic dysregulation |
|
| TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses. |
|
| TAp73 is required for spermatogenesis and the maintenance of male fertility |
|
| TAp73 Isoforms and TGF-β Signaling Cooperate to Suppress Inducible Nitric Oxide Synthase Expression. |
|
| TAp73 knockout shows genomic instability with infertility and tumor suppressor functions |
|
| TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. |
|
| TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity |
|
| TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. |
|
| Les tumeurs pancréatiques sont elles innervées?. |
|
| Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development |
|
